Compare Wockhardt with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs DISHMAN PHARMA - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT DISHMAN PHARMA WOCKHARDT/
DISHMAN PHARMA
 
P/E (TTM) x -20.1 25.1 - View Chart
P/BV x 1.1 3.3 31.7% View Chart
Dividend Yield % 0.0 0.7 0.5%  

Financials

 WOCKHARDT   DISHMAN PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
DISHMAN PHARMA
Mar-16
WOCKHARDT/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,012374 270.3%   
Low Rs532129 412.3%   
Sales per share (Unadj.) Rs355.9197.8 179.9%  
Earnings per share (Unadj.) Rs-60.321.2 -284.2%  
Cash flow per share (Unadj.) Rs-46.834.7 -134.7%  
Dividends per share (Unadj.) Rs0.012.00 0.5%  
Dividend yield (eoy) %00.8 0.2%  
Book value per share (Unadj.) Rs257.8179.9 143.3%  
Shares outstanding (eoy) m110.6380.69 137.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.21.3 170.5%   
Avg P/E ratio x-12.811.9 -107.9%  
P/CF ratio (eoy) x-16.57.2 -227.7%  
Price / Book Value ratio x3.01.4 214.0%  
Dividend payout %09.4 -0.2%   
Avg Mkt Cap Rs m85,37920,306 420.5%   
No. of employees `0006.30.8 754.4%   
Total wages/salary Rs m9,3715,355 175.0%   
Avg. sales/employee Rs Th6,295.019,252.7 32.7%   
Avg. wages/employee Rs Th1,498.36,459.5 23.2%   
Avg. net profit/employee Rs Th-1,066.32,064.1 -51.7%   
INCOME DATA
Net Sales Rs m39,36915,961 246.7%  
Other income Rs m1,202265 453.0%   
Total revenues Rs m40,57116,226 250.0%   
Gross profit Rs m184,103 0.4%  
Depreciation Rs m1,4951,091 137.1%   
Interest Rs m2,555944 270.5%   
Profit before tax Rs m-2,8302,334 -121.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257624 41.2%   
Profit after tax Rs m-6,6691,711 -389.7%  
Gross profit margin %025.7 0.2%  
Effective tax rate %-9.126.7 -34.0%   
Net profit margin %-16.910.7 -158.0%  
BALANCE SHEET DATA
Current assets Rs m33,79611,018 306.7%   
Current liabilities Rs m26,9179,517 282.8%   
Net working cap to sales %17.59.4 185.8%  
Current ratio x1.31.2 108.5%  
Inventory Days Days79110 71.8%  
Debtors Days Days8935 256.1%  
Net fixed assets Rs m39,66416,304 243.3%   
Share capital Rs m553161 342.8%   
"Free" reserves Rs m27,96812,907 216.7%   
Net worth Rs m28,52214,516 196.5%   
Long term debt Rs m21,7314,189 518.7%   
Total assets Rs m81,62029,805 273.8%  
Interest coverage x-0.13.5 -3.1%   
Debt to equity ratio x0.80.3 264.0%  
Sales to assets ratio x0.50.5 90.1%   
Return on assets %-5.08.9 -56.6%  
Return on equity %-23.411.8 -198.3%  
Return on capital %-7.717.5 -43.8%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m9,8074,952 198.1%   
Fx outflow Rs m1,789697 256.7%   
Net fx Rs m8,0194,255 188.5%   
CASH FLOW
From Operations Rs m6842,786 24.6%  
From Investments Rs m6,302-1,529 -412.2%  
From Financial Activity Rs m-7,695-941 817.6%  
Net Cashflow Rs m-664316 -209.9%  

Share Holding

Indian Promoters % 74.5 61.4 121.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 3.7 62.2%  
FIIs % 7.7 12.7 60.6%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 22.1 69.7%  
Shareholders   67,757 46,261 146.5%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   SUVEN LIFESCIENCES  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  SUN PHARMA  

Compare WOCKHARDT With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (1QFY19); Net Profit Down 81.4% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, WOCKHARDT LTD. has posted a net profit of Rs 862 m (down 81.4% YoY). Sales on the other hand came in at Rs 10 bn (up 13.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Oct 22, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT - ASTRAZENECA PHARMA COMPARISON

COMPARE WOCKHARDT WITH

MARKET STATS